These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9493861

  • 1. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
    Meereis-Schwanke K, Klonowski-Stumpe H, Herberg L, Niederau C.
    Peptides; 1998; 19(2):291-9. PubMed ID: 9493861
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G, Papp M, Scarpignato C.
    Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
    [Abstract] [Full Text] [Related]

  • 7. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C, Varga G, Dobronyi I, Papp M.
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
    Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB.
    Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
    [Abstract] [Full Text] [Related]

  • 10. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
    Sperti C, Militello C, Rovati L, Behboo R, Khajeturian E, Perasole A, Alaggio R, Pedrazzoli S.
    J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
    [Abstract] [Full Text] [Related]

  • 11. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [Abstract] [Full Text] [Related]

  • 12. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
    Gutzwiller JP, Drewe J, Ketterer S, Hildebrand P, Krautheim A, Beglinger C.
    Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R189-95. PubMed ID: 10896881
    [Abstract] [Full Text] [Related]

  • 13. Devazepide alters meal patterns in lean, but not obese, male Zucker rats.
    Strohmayer AJ, Greenberg D.
    Physiol Behav; 1994 Nov; 56(5):1037-9. PubMed ID: 7824568
    [Abstract] [Full Text] [Related]

  • 14. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR, Savastano DM, Covasa M.
    Physiol Behav; 2004 Sep 30; 82(4):663-9. PubMed ID: 15327914
    [Abstract] [Full Text] [Related]

  • 15. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A, Kulesza E, Konturek SJ.
    Scand J Gastroenterol; 1990 Jul 30; 25(7):731-8. PubMed ID: 2396088
    [Abstract] [Full Text] [Related]

  • 16. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats.
    Nakano S, Kihara Y, Otsuki M.
    Pancreas; 1998 Mar 30; 16(2):169-75. PubMed ID: 9510141
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
    Papp M, Varga G, Folly G.
    Acta Physiol Hung; 1991 Mar 30; 78(1):61-7. PubMed ID: 1722380
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P, Ensinck JW, Ketterer S, Delco F, Mossi S, Bangerter U, Beglinger C.
    J Clin Endocrinol Metab; 1991 May 30; 72(5):1123-9. PubMed ID: 2022712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.